MX2015016825A - Compuestos de pirazol como moduladores del receptor de hormona estimuladora de foliculos y sus usos. - Google Patents
Compuestos de pirazol como moduladores del receptor de hormona estimuladora de foliculos y sus usos.Info
- Publication number
- MX2015016825A MX2015016825A MX2015016825A MX2015016825A MX2015016825A MX 2015016825 A MX2015016825 A MX 2015016825A MX 2015016825 A MX2015016825 A MX 2015016825A MX 2015016825 A MX2015016825 A MX 2015016825A MX 2015016825 A MX2015016825 A MX 2015016825A
- Authority
- MX
- Mexico
- Prior art keywords
- fshr
- modulators
- pyrazole compounds
- useful
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La presente invención se refiere a compuestos pirazol, y sus composiciones farmacéuticamente aceptables, útiles como moduladores alostéricos positivos del receptor de hormona estimuladora de folículo (FSHR).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361838460P | 2013-06-24 | 2013-06-24 | |
US201361898608P | 2013-11-01 | 2013-11-01 | |
PCT/US2014/043838 WO2014209980A1 (en) | 2013-06-24 | 2014-06-24 | Pyrazole compounds as modulators of fshr and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015016825A true MX2015016825A (es) | 2016-04-18 |
Family
ID=51177212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015016825A MX2015016825A (es) | 2013-06-24 | 2014-06-24 | Compuestos de pirazol como moduladores del receptor de hormona estimuladora de foliculos y sus usos. |
Country Status (16)
Country | Link |
---|---|
US (2) | US10081637B2 (es) |
EP (1) | EP3013832B1 (es) |
JP (1) | JP6625973B2 (es) |
KR (2) | KR20210114561A (es) |
CN (1) | CN105473596B (es) |
AU (1) | AU2014302712B2 (es) |
BR (1) | BR112015030387B1 (es) |
CA (1) | CA2912921C (es) |
ES (1) | ES2849434T3 (es) |
HK (1) | HK1218757A1 (es) |
IL (1) | IL243226B (es) |
MX (1) | MX2015016825A (es) |
RU (1) | RU2663898C2 (es) |
SG (1) | SG11201509411VA (es) |
WO (1) | WO2014209980A1 (es) |
ZA (1) | ZA201508514B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015196335A1 (en) * | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Pyrazole compounds as modulators of fshr and uses thereof |
WO2016174616A1 (en) * | 2015-04-30 | 2016-11-03 | Novartis Ag | Fused tricyclic pyrazole derivatives useful for modulating farnesoid x receptors |
CN106977523A (zh) * | 2017-03-30 | 2017-07-25 | 河南师范大学 | 具有苯基并四氢吡咯结构的fshr拮抗剂及其制备方法 |
CN106967076A (zh) * | 2017-03-30 | 2017-07-21 | 河南师范大学 | 一种具有6h‑二苯并吡喃结构化合物及其制备方法 |
CN106928243A (zh) * | 2017-03-30 | 2017-07-07 | 毛阿龙 | 具有生物活性的苯并哌啶并苯胺基类化合物的制备方法 |
RU2716597C1 (ru) * | 2019-11-29 | 2020-03-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) | Производные 2-(хромено[4,3-d]пиримидин-5-ил)уксусной кислоты и способ их получения |
CN113754678B (zh) * | 2020-06-02 | 2023-03-10 | 江苏恒瑞医药股份有限公司 | 二氢硫代色烯并吡唑类衍生物、其制备方法及其在医药上的应用 |
WO2022007924A1 (zh) * | 2020-07-09 | 2022-01-13 | 江苏恒瑞医药股份有限公司 | 氧杂氮杂双环类衍生物、其制备方法及其在医药上的应用 |
TW202214656A (zh) | 2020-07-29 | 2022-04-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 氧氮雜環螺環衍生物、其製備方法及其醫藥用途 |
CA3235146A1 (en) | 2021-10-14 | 2023-04-20 | Incyte Corporation | Quinoline compounds as inhibitors of kras |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8814586D0 (en) | 1988-06-20 | 1988-07-27 | Erba Carlo Spa | Tricyclic 3-oxo-propanenitrile derivatives & process for their preparation |
US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
IL141063A (en) | 1998-08-07 | 2005-06-19 | Applied Research Systems | Derivatives of pyrrolidine-2-carboxylic acid and piperidine-2-carboxylic acids and pharmaceutical compositions comprising said derivatives for treating infertility |
WO2002009706A1 (en) | 2000-07-27 | 2002-02-07 | Smithkline Beecham Corporation | Agonists of follicle stimulating hormone activity |
SE0102404D0 (sv) * | 2001-07-04 | 2001-07-04 | Active Biotech Ab | Novel immunomodulating compounds |
ES2286275T3 (es) * | 2001-09-19 | 2007-12-01 | Pharmacia Corporation | Compuestos de pirazolo sustituidos para el tratamiento de la inflamacion. |
CN100436445C (zh) * | 2003-02-07 | 2008-11-26 | 第一制药株式会社 | 吡唑衍生物 |
ATE478859T1 (de) | 2003-02-07 | 2010-09-15 | Daiichi Sankyo Co Ltd | Pyrazolderivat |
WO2008035356A2 (en) * | 2006-09-20 | 2008-03-27 | Glenmark Pharmaceuticals Limited | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
WO2009010824A1 (en) * | 2007-07-13 | 2009-01-22 | Glenmark Pharmaceuticals, S.A. | Dihydrochromenopyrazole derivatives as vanilloid receptor ligands |
US20100298306A1 (en) * | 2007-10-22 | 2010-11-25 | Memory Pharmaceuticals Corporation | (1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of Disease |
US20110263588A1 (en) | 2008-10-27 | 2011-10-27 | Glaxo Group Limited | Tricyclic compounds as glutamate receptor modulators |
IT1394400B1 (it) * | 2009-02-25 | 2012-06-15 | Neuroscienze Pharmaness S C Ar L | Composizioni farmaceutiche |
IT1393930B1 (it) * | 2009-02-25 | 2012-05-17 | Neuroscienze Pharmaness S C A R L | Composti farmaceutici |
TWI461426B (zh) * | 2009-05-27 | 2014-11-21 | Merck Sharp & Dohme | (二氫)咪唑並異〔5,1-a〕喹啉類 |
TW201116515A (en) * | 2009-07-31 | 2011-05-16 | Organon Nv | Dihydrobenzoindazoles |
CA2778174C (en) * | 2009-11-13 | 2018-02-20 | Merck Serono S.A. | Tricyclic pyrazol amine derivatives as pi3k inhibitors |
-
2014
- 2014-06-24 CA CA2912921A patent/CA2912921C/en active Active
- 2014-06-24 WO PCT/US2014/043838 patent/WO2014209980A1/en active Application Filing
- 2014-06-24 BR BR112015030387-0A patent/BR112015030387B1/pt active IP Right Grant
- 2014-06-24 KR KR1020217029108A patent/KR20210114561A/ko not_active Application Discontinuation
- 2014-06-24 ES ES14739013T patent/ES2849434T3/es active Active
- 2014-06-24 AU AU2014302712A patent/AU2014302712B2/en active Active
- 2014-06-24 KR KR1020167000707A patent/KR102318498B1/ko active IP Right Grant
- 2014-06-24 RU RU2016101958A patent/RU2663898C2/ru active
- 2014-06-24 EP EP14739013.2A patent/EP3013832B1/en active Active
- 2014-06-24 SG SG11201509411VA patent/SG11201509411VA/en unknown
- 2014-06-24 MX MX2015016825A patent/MX2015016825A/es unknown
- 2014-06-24 US US14/900,209 patent/US10081637B2/en active Active
- 2014-06-24 JP JP2016521900A patent/JP6625973B2/ja active Active
- 2014-06-24 CN CN201480046771.2A patent/CN105473596B/zh active Active
-
2015
- 2015-11-18 ZA ZA2015/08514A patent/ZA201508514B/en unknown
- 2015-12-20 IL IL24322615A patent/IL243226B/en active IP Right Grant
-
2016
- 2016-06-13 HK HK16106787.6A patent/HK1218757A1/zh unknown
-
2018
- 2018-08-22 US US16/108,414 patent/US11365199B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2014302712B2 (en) | 2018-11-29 |
EP3013832A1 (en) | 2016-05-04 |
AU2014302712A1 (en) | 2015-12-03 |
NZ714201A (en) | 2021-02-26 |
IL243226B (en) | 2019-10-31 |
US20160152626A1 (en) | 2016-06-02 |
BR112015030387A2 (pt) | 2017-07-25 |
JP2016523865A (ja) | 2016-08-12 |
KR102318498B1 (ko) | 2021-10-27 |
CA2912921A1 (en) | 2014-12-31 |
BR112015030387B1 (pt) | 2021-02-09 |
SG11201509411VA (en) | 2015-12-30 |
KR20210114561A (ko) | 2021-09-23 |
CN105473596B (zh) | 2019-04-30 |
IL243226A0 (en) | 2016-02-29 |
RU2016101958A (ru) | 2017-07-28 |
RU2663898C2 (ru) | 2018-08-13 |
ZA201508514B (en) | 2019-07-31 |
CN105473596A (zh) | 2016-04-06 |
KR20160021817A (ko) | 2016-02-26 |
US11365199B2 (en) | 2022-06-21 |
HK1218757A1 (zh) | 2017-03-10 |
RU2016101958A3 (es) | 2018-03-29 |
JP6625973B2 (ja) | 2019-12-25 |
ES2849434T3 (es) | 2021-08-18 |
EP3013832B1 (en) | 2020-11-04 |
US20180354965A1 (en) | 2018-12-13 |
CA2912921C (en) | 2021-05-18 |
BR112015030387A8 (pt) | 2019-12-24 |
US10081637B2 (en) | 2018-09-25 |
WO2014209980A1 (en) | 2014-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015016825A (es) | Compuestos de pirazol como moduladores del receptor de hormona estimuladora de foliculos y sus usos. | |
MX2017000182A (es) | Compuestos de pirazol como moduladores de fshr y usos de los mismos. | |
JO3773B1 (ar) | معدلات p2x7 | |
PH12015502621A1 (en) | Estrogen receptor modulator and uses thereof | |
PH12016502479A1 (en) | Formulated receptor polypeptides and related methods | |
PH12015501996B1 (en) | Heterocyclic compounds and uses thereof | |
MX2015016171A (es) | Moduladores del receptor de estrogeno de azetidina y usos de los mismos. | |
MX2021001231A (es) | Compuestos heterociclicos y sus usos. | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
NZ766530A (en) | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | |
GEP201706710B (en) | Imidazopyridazine derivatives as gabaa receptor modulators | |
MD20170048A2 (ro) | Formulare pe bază de acetat de abirateronă şi procedee de utilizare a acesteia | |
MX2017003254A (es) | 2-azabiciclos sustituidos y su uso como moduladores de receptores de orexina. | |
PH12017501280B1 (en) | Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators | |
MX2015011536A (es) | Nuevos antagonistas de receptores trpa1 de sulfamidas. | |
IN2013MU03641A (es) | ||
AU2014324961A8 (en) | Highly potent glucocorticoids | |
MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
MX2015016603A (es) | Composiciones de corticosteroides. | |
MX2023001906A (es) | Diarilureas como moduladores alostericos de cannabinoide cb1. | |
IN2013MU03565A (es) | ||
MX2017005669A (es) | Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos. | |
LV15016A (lv) | N-karbamoilmetil-4(R)-fenil-2-pirolidinona polimorfās formas | |
IN2013CH02437A (es) | ||
GEP201706747B (en) | Pharmaceutical composition for reducing the trimethylamine n-oxide level |